Home » Topics » Conferences

Conferences
RSS

TM-38837 shows favorable safety and pharmacokinetics in healthy subjects

Aug. 5, 2010

Japanese scientists identify potential biomarkers for coronary artery disease

Aug. 5, 2010

Candesartan inhibits fibrosis in rat model of RMI by suppressing sFRP-2

Aug. 5, 2010

TBR-652 exhibits potent anti-HIV activity in phase II trial

Aug. 4, 2010

Reduced TSPO expression and low progesterone are linked to MDD

Aug. 3, 2010

Promising preliminary phase II data disclosed on HIV immunotherapeutic AGS-004

Aug. 3, 2010

Suven Life Sciences presents new agents with encouraging in vivo procognitive activity

Aug. 3, 2010

Astaxanthin derivatives show promise in preclinical models of cardiovascular inflammation

Aug. 2, 2010

Sexual dysfunction in schizophrenia linked to typical antipsychotics, prolactin and DRD2 genotype

Aug. 2, 2010

Several phase II trials support safety and tolerability of BMS-708163 in healthy subjects

Aug. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...